Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-06-28
2010-11-23
Seaman, D. Margaret (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S113000
Reexamination Certificate
active
07838533
ABSTRACT:
The present invention relates to 7-azaindole-based compounds, to processes for the preparation thereof, to pharmaceutical compositions comprising them, and to the use thereof in the preparation of medicaments that are useful as inhibitors of MTP and of ApoB secretion.
REFERENCES:
patent: 3362956 (1968-01-01), Archer
patent: 3511841 (1970-05-01), Archer
patent: 4939159 (1990-07-01), Anderson et al.
patent: 5684014 (1997-11-01), Mueler et al.
patent: 6979692 (2005-12-01), Bertinato et al.
patent: 2005/0239780 (2005-10-01), Suga
patent: 2006/0100230 (2006-05-01), Bischoff et al.
patent: 1 367 058 (2003-12-01), None
patent: WO 03/002533 (2003-01-01), None
patent: WO 2004/005253 (2004-01-01), None
Chevreuil Olivier
Guevel Alyx Caroline
Roux Bruno
Vidal Catherine
Merck Patent GmbH
Millen White Zelano & Branigan P.C.
Rahmani Niloofar
Seaman D. Margaret
LandOfFree
Azaindole inhibitors of MTP and ApoB does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Azaindole inhibitors of MTP and ApoB, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Azaindole inhibitors of MTP and ApoB will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4235937